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CD44 Disruption Attenuates Murine Hepatic Ischemia/Reperfusion 
Injury
Neutrophil adhesion and migration are critical in hepatic ischemia/reperfusion (I/R) injury. 
Despite very strong preclinical data, recent clinical trials failed to show a protective effect 
of anti-adhesion therapy in reperfusion injury. Therefore, the aim of this study was to 
assess the role of CD44 in neutrophil infiltration and liver injury from hepatic I/R. In this 
study, using a partial hepatic ischemic model in vivo, we determined the potential role of 
CD44 in neutrophil infiltration and liver injury from I/R. Reperfusion caused significant 
hepatocellular injury as it was determined by plasma ALT levels and liver histopathology. 
The injury was associated with a marked neutrophil recruitment and CD44 expression into 
the ischemic livers. Administration of anti-CD44 antibody to mice reduced the infiltration 
of neutrophil into the ischemic tissue, associated with liver function preservation. These 
results support crucial roles of CD44 in neutrophil recruitment and infiltration leading to 
liver damage in hepatic I/R injury. Moreover, they provide the rationale for targeting to 
CD44 as a potential therapeutic approach in liver I/R injury.
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INTRDUCTION
Hepatic ischemia reperfusion (I/R) injury is a pathophysiologic 
process whereby hypoxic organ damage is accentuated follow-
ing return of blood flow and oxygen delivery (1-3). Transient 
episodes of tissue ischemia are encountered during solid organ 
transplantation, trauma, hypovolemic shock and elective liver 
resection, when inflow occlusion or total vascular exclusion is 
used to minimize blood loss. In these situations, after a period 
of ischemia, the liver can be significantly injured upon its reper-
fusion. If the injury is severely uncontrolled, this can lead to liv-
er failure, systemic inflammatory response syndrome and mul-
tiple organ failure which are associated with high rates of mor-
bidity and mortality (4).
  I/R injury is characterized by an excessive inflammatory re-
sponse after reperfusion, which exert a crucial role in the patho-
physiology of postischemic hepatic failure (5). The injury occurs 
in a biphasic pattern: The early pattern is characterized by hepat-
ic injury occurring within 1-6 hr after reperfusion, associated 
with Kupffer cell activation and up-regulation of reactive oxy-
gen species, the inducible nitric oxide synthase and the pro-in-
flammatory cytokines (6, 7). Subsequently, the injury is aggra-
vated by a massive neutrophil infiltration, peaking 9-24 hr fol-
lowing reperfusion. The neutrophils are recruited into the liver 
vasculature, which is activated by various cellular adhesion mol-
ecules. These neutrophils cause hepatocyte necrosis through 
the release of cytotoxic proteases and oxygen-derived radicals. 
  The neutrophil recruitment during inflammation is classical-
ly attributed to a multi-step cascade involving initial tethering 
and rolling along the vessel wall, followed by firm adhesion to 
the vascular endothelium and emigration out of the vasculature. 
This classical paradigm is well characterized for a number of or-
gan microvasculatures including mesentery, peritoneum, skele-
tal muscle, and skin (8). Within the post-capillary vessels of these 
tissues, the classical paradigm of neutrophil recruitment involve 
selectin mediated tethering and rolling, followed by integrin me-
diated firm adhesion (9). The liver has two principal vascular 
beds for neutrophil recruitment during reperfusion: sinusoids 
and postsinusoidal venules. The evidence for transmigration 
from postsinusoidal venules is limited. In contrast, sinusoids 
were identified as the dominant sites for neutrophil extravasa-
tion (10). The sinusoidal endothelium is the unique structure of 
the liver, which is discontinuous, fenestrated, and lacking basal 
lamina and tight junction. And then in these narrow capillaries, 
the recruitment of slow-moving leukocytes is selectin indepen-
dent, and the rolling process is likely to be unnecessary. In short, 
the liver presents an apparent exception to this classical para-
digm of neutrophil recruitment in three ways: 1) in addition to 
the postsinusoidal venules, neutrophils also adhere to the en-
dothelium of capillaries called sinusoids, 2) within the sinusoids, Kim MS, et al.  •  The Role Of CD44 In Murine Hepatic Ischemia/Reperfusion Injury 
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neutrophils appear not to roll for a significant distance, but rather 
tether and immediately adhere and 3) the adhesion in the sinu-
soids is shown to be completely independant of selectin (11, 12).
  Some clinical trials of anti-adhesion therapy in an attempt to 
reduce injury associated with I/R injury failed to show a signifi-
cant benefit, despite very strong preclinical data (13). Recently, 
several adhesion molecules, including VAP-1, CD44, CD43, and 
Fcγ RIII for lymphocyte adhesion in sinusoidal endothelium 
have been proposed (14). Therefore, we examined the role of 
CD44 in liver reperfusion injury, at various lengths of reperfu-
sion time. In current study, we sought to test whether or not he-
patic I/R injury would be attenuated in mice treated with anti-
CD44 antibody before I/R insult, at time points most consistent 
with the neutrophil-mediated phage of liver injury.
MATERIALS AND METHODS
Animals
Male wild-type (C57BL/6) mice (8-12 week old) were purchased 
from the Jackson Laboratory. All animals were maintained in a 
laminar-flow, specific pathogen-free atmosphere at the Eulji 
University School of Medicine. The protocol for animal experi-
ment in this article was previously approved by the Institutional 
Animal Care and Use Committee of the Eulji University School 
of Medicine (EIACUC 09-01). All subsequent animal experiment 
adhered to the “Regulation for Animal Expermentation” of the 
University.
Liver ischemia
A nonlethal model of segmental (70%) hepatic warm ischemia 
was used (15). The I/R protocol was initiated with the abdomi-
nal wall being clipped of hair and cleansed with betadine. Un-
der sodium pentobarbital (40 mg/kg, intraperitonal) and me-
thoxyflurane (inhalation) anesthesia, a midline laparotomy was 
performed. With the use of an operating microscope, the liver 
hilum was dissected free of surrounding tissue. All structures in 
the portal triad (hepatic artery, portal vein, and bile duct) to the 
left and median liver lobes were occluded with a microvascular 
clamp (Fine Science Tools) for 60 min, and reperfusion was ini-
tiated by removal of the clamp. This method of segmental hepat-
ic ischemia prevents mesenteric venous congestion by permit-
ting portal decompression through the right and caudate lobes. 
We have previously conducted a time course experiment to de-
termine the optimal ischemia time period for the induction of 
hepatic injury. Less than 60 min of ischemia produced only min-
imal plasma transaminase elevations, whereas over 75 min of 
ischemia was poorly tolerated with gross evidence of poor re-
perfusion of the ischemic lobes. A reproducible level of hepatic 
damage was observed using 60 min of ischemia and was thus 
used for our study. After application of the clamp, the abdomen 
was covered with a sterile plastic wrap to minimize evaporative 
loss. Throughout the ischemic interval, evidence of ischemia 
was confirmed by visualizing the pale blanching of the ischemic 
lobes. The clamp was then removed and gross evidence of re-
perfusion based on immediate color change was assured be-
fore closing the abdomen with a continuous 4-0 diameter poly-
propylene suture. Either the absence of ischemic color changes 
or the lack of response to reperfusion was a criterion for imme-
diate sacrifice and exclusion from further analysis. Temperature 
was monitored by rectal temperature probe and was maintained 
at 37°C by means of a warming pad and heat lamp. At the end 
of the observation period following reperfusion, the mice were 
anesthetized with inhaled methoxyflurane and were sacrificed 
by exsanguination. Sham animals underwent anesthesia, lapa-
rotomy, and exposure of the portal triad without hepatic isch-
emia. Animals were sacrificed at predetermined time points (6-
72 hr) after reperfusion to obtain serum and liver samples. An-
tibody-treated mice received 16 hr before surgery a single intra-
peritoneal injection of 100 μg of anti-CD44 mAb (16) (clone IM 
7, purified rat anti-mouse CD44; BD Pharmingen, San Diego, 
CA, USA) that interacts with the HA-binding site of CD44 and 
may induce shedding of CD44 or control IgG (normal rat IgG; 
Santa Cruz, CA, USA).
 
Peripheral blood and tissue procurement
Blood samples were collected from the right ventricle via medi-
an sternotomy in a sterile heparinized syringe containing 50 μL 
of heparin (100 USP units/mL). The blood samples were centri-
fuged and plasma were collected and stored at -80°C until fur-
ther use. Portions of the ischemic and non-ischemic liver lobes 
were fixed in buffered 10% formalin, embedded in paraffin, and 
used for hematoxylin and eosin (H&E) staining and immuno-
histochemical study. Other portions of ischemic and non-isch-
emic liver lobes were snap frozen in liquid nitrogen and stored 
at -80°C, until use for western blotting analysis.
Liver damage assessment
To assess hepatic function and cellular injury following liver isch-
emia, serum alanine aminotransferase (ALT) levels were mea-
sured using the Opera Clinical Chemistry System (Bayer, Mu-
nich, Germany).
Plasma cytokine concentrations
Plasma TNF-α, IL-6, and MCP-1 levels were determined in a 96-
well Nunc-Immuno microplate (VWR Scientific, Chicago, IL, 
USA), using a sandwich enzyme-linked immunosorbent assay 
(ELISA). The capture antibody was a polyclonal anti-mouse 
TNF-α, IL-6, or MCP-1 specific goat IgG (R&D Systems, Minne-
apolis, MN, USA) and the detection antibody was a biotinylated 
polyclonal anti-mouse TNF-α, IL-6, or MCP-1 specific goat IgG 
(R&D Systems). All plasma samples were tested in duplicate. 
The minimal detectable protein concentration was 20 pg/mL.Kim MS, et al.  •  The Role of CD44 in Murine Hepatic Ischemia/Reperfusion Injury 
http://jkms.org   921 DOI: 10.3346/jkms.2011.26.7.919
Histopathological study
Formalin-fixed liver samples were embedded in paraffin and 
cut to 5 μm thick sections. Tissues were stained with hematoxy-
lin-eosin, and slides were assessed for inflammation and tissue 
injury. The percent necrotic area was estimated by random eval-
uation of lower power fields (× 40) of each hematoxylin-eosin-
stained section. A pathologist, blinded to the experimental pro-
cedure of the mice, examined the histopathology of the hepatic 
tissue sections.
Immunohistochemical staining
Tissue sections in 5 μm thickness were prepared from paraffin-
embedded tissue blocks. Tissue sections were deparaffinized in 
xylene and rehydrated in a series of ethanol. Microwaving anti-
gen retrieval was performed in 0.01 M citrate buffer, pH 6.0, for 
10 min. Then, tissue sections were placed in 0.3% H2O2/metha-
nol for 15 min to inactivate endogenous peroxidase. After wash-
ing in PBS, tissue sections were incubated in 10% normal goat 
serum (Chemicon International, Temecula, CA, USA) for 30 min 
at room temperature to block nonspecific binding of the prima-
ry antibody. Then, tissue sections were exposed to diluted pri-
mary antibody for overnight at 4°C. Proper dilutions of primary 
antibodies were selected from preliminary studies. We used di-
lutions of 1:200 for CD44 (monoclonal rat anti-mouse CD44; BD 
Pharmingen, Franklin Lakes, NJ, USA) and 1:25 for neutrophil 
(monoclonal rat anti-neutrophil; Abcam, Cambridge, MA, USA). 
After washing in PBS to remove excess primary antibody, tissue 
sections were then incubated with biotinylated goat anti-rat IgG 
(SC-2041, Santa Cruz, Santa Cruz, CA, USA) at 1:100 dilution for 
1 hr at room temperature. Unbound secondary antibody was 
removed with PBS washing, and avidin-biotin peroxidase (Vec-
tor Laboratories, Burlingame, CA, USA) was placed on tissue sec-
tions for 30 min at room temperature. The positive immune-re-
activity on tissue sections was detected by treatment with a mix-
ture of 3,3´-diaminobenzidine (Sigma, St. Louis, MO, USA), 0.05 
M Tris-HCl buffer, and 5% hydrogen peroxide. Then, the tissue 
sections were counterstained with hematoxylin, followed by de-
hydration in a series of ethanol. Immunostaining was examined 
and evaluated under light microscopy. For negative control, nor-
mal goat serum at the same dilutions in the place of primary an-
tibody was treated on tissue sections. 
 
SDS-PAGE and western blot analysis
After protein concentration was determined using the BCA pro-
tein assay, equal volumes of elute were fractioned by SDS-PAGE 
and transferred to nitrocellulose membranes for 2 hr at 250 mA 
in the presence of transfer buffer. The transferred membrane 
was blocked for 1 hr at room temperature with 5% milk in TBS-
T buffer and incubated with purified rat anti-mouse CD44 mAb 
(KM114; BD Pharmingen), rat anti-mouse neutrophil mAb (clone 
7/4; Abcam) respectively for 12 hr at 4°C. Blots were incubated 
at room temperature for 1 hr with a horseradish peroxidase-
conjugated secondary antibody against the primary antibody. 
After extensive washing with TBS-T buffer, membranes were 
developed with the Super Signal West Pico chemiluminescent 
kit (Pierce Chemical Co., IL, USA) and exposed to film.
Statistical analysis
Results were expressed as the mean ± SEM. Group comparisons 
were performed using Student’s t test or analysis of variance. Dif-
ferences were considered significant at P < 0.05.
RESULTS
Demonstration of hepatocellular injury by changes in 
reperfusion time
Hepatic I/R caused significant hepatocellular damage as dem-
onstrated by plasma ALT levels. The plasma ALT levels of wild-
type mice after 60 min. of ischemia followed by serial time in-
terval of reperfusion were measured. The plasma ALT level was 
maximally elevated after 6 h of reperfusion following ischemic 
insult, which was decreased to level of sham operation after 72 
hr (Fig. 1).
Demonstration of inflammatory cytokine levels by 
changes in reperfusion time
In order to determine whether plasma cytokine/chemokine lev-
els correlated with tissue injury, the plasma cytokine/chemokine 
levels were measured using an ELISA. The plasma levels of all 
cytokines/chemokine (i.e., TNF-α, IL-6, and MCP-1) were sig-
nificantly increased in response to I/R and reached their maxi-
mum at 6 hr of reperfusion, which then declined to baseline by 
24 hr of reperfusion (Fig. 2). As Fig. 2 shows, hepatic I/R caused 
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Fig. 1. Time-course of plasma ALT levels following hepatic I/R. Mice were subjected 
to 60 min of ischemia followed by reperfusion with various lengths of time. “Sham” 
indicates mice that underwent surgical procedure without vascular occlusion followed 
by reperfusion, while “I/R” denote mice that underwent surgical procedure with vas-
cular occlusion for 60 min followed by reperfusion for various lengths of time. Serum 
ALT levels were analyzed as a measure of hepatocellular injury. Values are expressed 
as mean ± SE, n = six mice per each time point/group.Kim MS, et al.  •  The Role Of CD44 In Murine Hepatic Ischemia/Reperfusion Injury 
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significant elevation of TNF-α at 6 hr of reperfusion, which was 
declined at 24 hr of reperfusion. This data paralleled plasma ALT 
data, which showed at 6 hr after ischemic insult, followed by a 
decrease in levels until 72 hr of reperfusion. A similar pattern 
was observed in plasma IL-6 and MCP-1 levels.
CD44 expression is up-regulated in the liver after I/R
To determine if the CD44-dependent injury was associated with 
change in protein levels, Western blot analysis was performed 
on liver lysates from animals that were subjected to liver I/R (Fig. 
3A). Following 60 min of warm ischemia, CD44 protein expres-
sion was up-regulated as early as 6 hr after reperfusion and then 
increased in a time dependent manner up to 24 hr. To quantify 
the amount of protein, a densitometer was used. The values of 
CD44 in I/R mice were higher by comparison with the values of 
CD44 in sham mice. The differences were statistically significant 
(Fig. 3B).
Hepatocellular injury is related to CD44 and neutrophil 
recruitment in the liver after I/R
Mice were subjected to 60 min of ischemia followed by reperfu-
sion at the time point of 6 hr and 24 hr. The ischemic liver sec-
tions were prepared and stained with H&E and then immuno-
histochemical staining of CD44 and neutrophils using specific 
anti-CD44 monoclonal antibody and anti-neutrophil antibody. 
The histopathologic injury of the liver tissue was evaluated based 
on sinusoidal congestion, cytoplasmic vacuolization, hepato-
cellular necrosis, and neutrophil infiltration. The liver sections 
from the sham-operated mice displayed no necrosis, similar to 
that of the non-operated control mice (Fig. 4A). Additionally, 
there was no apparent evidence of hepatic injury due to isch-
emia alone (i.e., at zero hour of reperfusion; image not shown). 
However, reperfusion of the ischemic liver induced an extensive 
hepatocellular necrosis, sinusoidal congestion, and neutrophil 
infiltration after 6 and 24 hr of reperfusion in wild-type mice (Fig. 
4D, G). There was sparing of the periportal areas with progres-
sively increased injury approaching the central vein. 
  CD44 expression is indicated by dark brown color stain. There 
was progressively increased CD44 expression approaching the 
central vein (Fig. 4B, E, H). A similar pattern was observed in neu-
trophil infiltration. The injury was associated with a marked num-
ber of neutrophils infiltrated into the midzonal region of isch-
emic liver after 6 and 24 hr of reperfusion, which was confirmed 
with in situ immunohistochemical staining of the neutrophils. 
Neutrophils are also indicated by dark brown color stain (Fig. 
4C, F, I).
 
Pretreatment of neutralizing antibody to CD44 protects 
against hepatic I/R injury
To determine if endogenous CD44 contributed to organ damage 
after hepatic I/R, neutralizing antibody to CD44 was adminis-
tered to mice that were subjected to warm I/R. Mice received a 
single intraperitoneal injection of anti-CD44 mAb (100 μg per 
mouse) or control IgG antibody (100 μg per mouse) at 16 hr be-
fore surgery as previously described (15). Sixty minutes of warm 
hepatic ischemia were followed by 6 and 24 hr of reperfusion. 
Serum ALT levels were analyzed as a measure of hepatocellular 
injury. As Fig. 5A, B display, serum ALT levels in the mice with 
pretreatment of control IgG were significantly increased after 6 
and 24 hr of reperfusion. This data paralleled in initial I/R mice 
Fig. 2. Time-course of plasma TNF-α, MCP-1, and IL-6 levels. “Sham” indicates mice 
that underwent surgical procedure without vascular occlusion followed by reperfusion, 
while “I/R” indicates mice that underwent surgical procedure with vascular occlusion 
for 60 min followed by reperfusion at the time point shown. Initial proinflammatory 
cytokines such as TNF-α and IL-6 levels paralleled ALT plasma levels. Values are ex-
pressed as mean ± SE. n = six mice per each time point/group.
p
g
/
m
L
p
g
/
m
L
1,000
900
800
700
600
500
400
300
200
100
0
30
28
26
24
22
20
18
16
14
12
10
8
6
4
2
0
Sham I/R 6 hr I/R 24 hr
TNFα
IL-6
MCP-1
Fig. 3. CD44 expression is up-regulated in the liver after I/R. (A) Western blot analysis 
for CD44 and beta actin was performed for hepatic protein lysates of the ischemic lobes 
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Fig. 4. Hepatic histopathology following I/R. Mice were subjected to 60 min of ischemia followed by reperfusion at the time point shown. The ischemic liver sections were pre-
pared and stained with H&E and then immunohistochemical staining of CD44 and neutrophils using specific anti-CD44 monoclonal antibody and anti-neutrophil antibody. (A), 
(B), and (C) represent the sham mice. There are normal hepatic histology (A). Nornal liver lobule shows mildly positive CD44 immunostaining (B) and negative neutrophil immu-
nostaining (C). (D), (E), and (F) represent the mice subjected to 60 min of ischemia followed by reperfusion for 6 hr. The hepatic lobules show one focus of coagulation necrosis 
and adjacent ballooning degeneration (D). The liver shows moderately positive CD44 immunostaining (E) and focal a few positive neutrophil cells (F). (G), (H) and (I) represent 
the mice subjected to 60 min of ischemia followed by reperfusion for 24 hr. There are several large areas of coagulation necrosis and neutrophilic infiltration (G). The liver shows 
obiously patchy increased CD44 immunostaining (H) and neutrophil influx (I).
H&E stain (× 400) CD44 immunostain (× 400) Neutrophil immunostain (× 400)
Sham
I/R 6 hr
I/R 24 hr
A C B
D F E
G H I
Fig. 5. Pretreatment of neutralizing antibody to CD44 protects against liver I/R injury. (A) and (B) represent plasma ALT levels from mice that underwent liver I/R injury and mice 
that were pretreated by neutralizing antibody at the time point shown. Antibody-treated mice received 16 hr before surgery a single intraperitoneal injection of 100 µg of anti-
CD44 mAb or control IgG. Serum ALT levels were analyzed as a measure of hepatocellular injury. Values are expressed as mean ± SE, n = six mice per each time point/group. 
*P < 0.05 versus mice that were subjected to I/R and given anti-CD44 mAb. (C) and (D) represent H&E stained liver sections from mice that were pretreated by control antibody 
and anti-CD44 mAb before liver I/R injury (original magnification × 400). Images are representative liver sections from six mice per group.
P
l
a
s
m
a
 
A
L
T
 
l
e
v
e
l
s
 
(
I
U
/
L
)
P
l
a
s
m
a
 
A
L
T
 
l
e
v
e
l
s
 
(
I
U
/
L
)
3,000
2,500
2,000
1,500
1,000
500
0
700
600
500
400
300
200
100
0
Sham Sham I/R 6 hr I/R 24 hr Control IgG-I/R6 Control IgG-I/R24 CD44 mAb-I/R6 CD44 mAb-I/R24
* *
A
C D
B
IgG-6 hr I/R IgG-24 hr I/R CD44 mAb-6 hr I/R CD44 mAb-24 hr I/RKim MS, et al.  •  The Role Of CD44 In Murine Hepatic Ischemia/Reperfusion Injury 
924   http://jkms.org DOI: 10.3346/jkms.2011.26.7.919
experiment. However, the serum ALT levels in the mice with pre-
treatment of anti-CD44 mAb were declined after 6 and 24 hr of 
reperfusion. The differences compared with the control IgG treat-
ed mice were statistically significant (Fig. 5A, B). Treatment with 
anti-CD44 mAb resulted in significant protection from hepatic 
I/R injury at each time point. 
  Liver histology confirmed the serum ALT estimation of hepa-
tocellular damage. Liver sections from mice that were pretreat-
ed by control antibody and anti-CD44 mAb before hepatic I/R 
injury were stained with hematoxylin-eosin. Severe sinusoidal 
congestion and hepatocellular necrosis was present in liver tis-
sue from mice that were treated with control IgG, whereas min-
imal damage was noted in samples from anti-CD44 mAb-treat-
ed mice (Fig. 5C, D). Moreover, the disruption of CD44 and sub-
sequent inhibition of neutrophil recruitment was confirmed in 
ischemic liver after 6 and 24 hr of reperfusion by specific immu-
nohistochemical staining. After 6 and 24 hr reperfusion in he-
patic I/R mice, the CD44 expression and neutrophil influx were 
observed in the liver sections from control antibody treated mice. 
The other hand, immunostaining for CD44 revealed decreased 
in hepatic sinusoidal area of anti-CD44 mAb-treated mice com-
pared with given control antibody after I/R (Fig. 6A-D). The in-
filtration of neutrophils into anti-CD44 mAb-treated mice was 
impaired relative to given control antibody. This pattern of neu-
trophil influx was similar to that of CD44 immunostaining pat-
tern (Fig. 6E-H).
DISCUSSION
CD44 is constitutively expressed on leukocytes and parenchy-
mal cells including endothelial, epithelial and smooth muscle 
cells. During inflammation, CD44 expression is up-regulated on 
hematopoietic and parenchymal cells (17, 18). Several previous 
studies have indicated that CD44 is involved in a variety of in-
flammatory responses. The evidence that CD44 plays a crucial 
role in a variety of inflammatory diseases includes studies in 
which administration of anti-CD44 antibodies inhibited inflam-
mation in murine models of collagen- and proteoglycan-induced 
arthritis, experimental autoimmune encephalomyelitis, and IL-
2-induced vascular leak syndrome (19, 20). These suppressive 
effects are thought to be due to reductions in leukocyte recruit-
ment and activation. This has led to the suggestion that CD44 
should be considered as a target for novel interventions in in-
flammatory diseases. In our study, we showed that CD44 exert-
ed a crucial role in migration of neutrophils into the postischemic 
tissue from I/R. The CD44 blockade was shown to decrease neu-
trophil influx, reduce hepatic I/R injury, and preserve hepatic 
function.
  First, we showed that CD44 was rapidly up-regulated in post-
ischemic tissue. Although early after I/R injury, its expression 
was found on infiltrating leucocytes and sinusoidal endothelial 
cells, the CD44 expression actually was increased until 24 hr af-
ter I/R injury. These findings are in agreement with observations 
in testicular I/R injury. Moon et al. (21) showed that the expres-
sion of CD44 significantly increased and that abundant number 
Fig. 6. Immunohistochemical detection 
of CD44 and neutrophil influx in the liver. 
(A-D) represent immunohistochemical 
staining of CD44 in the liver sections 
from control antibody and anti-CD44 mAb-
treated mice that were subjected to 60 
minutes of ischemia followed by reper-
fusion at the shown time point. Immu-
nostaining for CD44 reveals decreased 
CD44 staining in hepatic sinusoidal area 
of anti-CD44 mAb-treated mice compared 
with given control antibody after I/R. (E-
H) represent immunohistochemical stain-
ing of neutrophil in the liver sections ad-
jacent to CD44 immunohistochemical 
staining. Impaired influx neutrophils into 
anti-CD44 mAb-treated mice relative to 
given control antibody was paralleled 
CD44 immunostianing pattern. Images 
are representative liver sections from six 
mice per group.
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of inflammatory cells infiltrated into the interstitial space sur-
rounding damaged semiferous tubule during the delayed phage 
(24-96 hr) after testicular I/R injury. Therefore, we can postulate 
that the CD44 leads to increase neutrophil-dominated liver in-
jury during the later phase after hepatic ischemia, as described 
earlier by Jaeschke (22). 
  Second, we demonstrated that disruption of CD44 attenuated 
hepatic injury after I/R and preserved hepatic function. Gener-
ally, the I/R injury is characterized by recruitment and infiltra-
tion of neutrophils into the postischemic tissue and accentuat-
ed by the release of cytotoxic proteases and oxygen-derived free 
radicals (23). In accordance, depletion of neutrophil recruitment 
into the postischemic tissue by blockade of cellular adhesion 
molecules decreases hepatic I/R injury (24). In our study, we 
found that infiltration of neutrophil into the postischemic tissue 
decreased significantly in CD44 mAb pre-treatment group. Our 
data agree with other animal model, including renal I/R injury 
(25), in which administration of an antibody that interact with 
the hyaluronan (HA)-binding site of CD44 induced shedding of 
CD44 and decreased neutrophil migration into the postischemic 
kidney. Moreover, injection of the antibody did not alter periph-
eral blood leukocyte numbers or neutrophil, lymphocyte, or 
monocyte counts. McDonald et al. (8) recently demonstrated 
that interaction of CD44 and HA is the dominant mechanism 
for neutrophil sequestration in inflamed liver sinusoids of mice 
in response of LPS (or bacterial endotoxin)-induced hepatic in-
jury. Since neutrophil recruitment occurs quite rapidly in for ex-
ample endotoxemia, it stands to reason that constitutively ex-
pressed or presynthesized molecules would be important in neu-
trophil recruitment into tissues. They suggested that CD44-me-
diated adhesion of neutrophils was independent of selectins. 
Then, RHAMM-1, another HA receptor, played no role in neu-
trophil adhesion in sinusoids. Moreover, they showed that hyal-
uronidase, an HA depleting enzyme, CD44-/- mice and anti-CD44 
antibody all reduced neutrophil adhesion in sinusoids and re-
duced tissue injury. Therefore, we can suggest that CD44 is con-
sidered as a target for novel interventions in hepatic I/R injruy.
  The significance of this study is the first description that the 
CD44, selectin-independent specific cellular adhesion mole-
cule on neutrophil or endothelium is important to pathophysi-
ological process in the liver from I/R injury. We hypothesized 
that CD44 exerts a crucial role of the migration of neutrophils 
into the postischemic tissue from I/R. However, there are some 
points that we were not entirely satisfied to elucidate the role of 
CD44 in hepatic I/R injury. The most clinically relevant findings 
reported in this study were the observation that improved hepat-
ic function and decreased neutrophil infiltration into the post-
ischemic tissue was ameliorated by administration of an anti-
CD44 mAb. 
  To determine whether our results could be valid for therapeu-
tic application, further studies are necessary to examine accu-
rate mechanism of CD44-HA interaction leading to neutrophil 
recruitment from hepatic I/R injury. The involvement of CD44 
in migration of neutrophils in extracellular matrix may vary ac-
cording to the distribution of HA contents (26). Therefore, the 
demonstration of HA at the cell surface of murine neutrophils 
is an important for elucidating mechanism of CD44-HA combi-
nation from hepatic I/R injury. Secondly, future studies are nec-
essary to examine the specific role of CD44 in recruitment of neu-
trophil from hepatic I/R. Khan et al. (27) showed that rolling of 
leukocytes in chronic inflammation by intrascrotally injected 
with the neutrophil-activating chemokine was not impaired in 
absence of CD44. This suggests that CD44 plays a specific role 
in the adhesion of neutrophil. Finally, our study is in part con-
sistent with wild type data, in that the up-regulation of the CD44 
correlated with hepatic injury and neutrophil infiltration during 
later-phage of hepatic I/R (i.e. 24 hr of reperfusion). However, 
previous studies have suggested that the neutrophil recruitment 
may haven mediated by other more potent chemoattractants and 
mediators (28, 29). Using wild-type and IL-1 receptor I-knockout 
(IL-1RI[-/-]) mice, Kato et al. (30) also showed that IL-1RI(-/-) 
mice had significantly less neutrophil accumulation in hepatic 
I/R. Thus, using CD44-/- or chimeric mice, future studies are 
necessary to confirm the potential role of CD44 in neutrophil 
recruitment from hepatic I/R.
  In conclusion, up-regulation of CD44 on sinusoidal endothe-
lial cells after I/R injury results in the recruitment of neutrophils 
into the postischemic tissue. The disruption of CD44 via neutral-
izing antibody to CD44 resulted in down-regulation of CD44, 
decreased influx of neutrophils and attenuation of hepatic I/R 
injury. Therefore, targeting CD44-HA interactions may be an in-
novative and efficient therapy to prevent or reduce I/R related 
hepatic injury.
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AUTHOR SUMMARY
CD44 Disruption Attenuates Murine Hepatic Ischemia/Reperfusion Injury
Min Sung Kim, Ki Ho Lee, Won Mee Lee, Jin Hyun Jun and Dong Hee Kim
Hepatic ischemia reperfusion (I/R) injury is a fatal pathophysiologic process that is encountered during liver transplantation, 
hypovolemic shock and elective liver resection. We hypothesized that CD44, a kind of cellular adhesion molecule is implicated in 
neutrophil recruitment and tissue injury from hepatic I/R. We determined neutrophil recruitment and CD44 expression in mouse 
hepatic I/R injury model. Also, we found protective effect of anti-CD44 antibody pretreatment on the inflammatory responses. 
These results support crucial roles for CD44 for neutrophil recruitment in hepatic I/R injury, and provide a rationale for targeting to 
CD44 as a potential therapeutic approach.